# Evotec SE (EVO): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/evo for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
- Exchange: NASDAQ · Trading currency: USD

Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and women's health. The company maintains strategic allia...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $1.50 USD |
| Market Cap | $532.8M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.73 |
| 52-Week Range | $1.33 – $4.27 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Monthly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | — / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

## Frequently Asked Questions

### What does Evotec SE do?

Evotec SE (EVO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is EVO's market cap?

Evotec SE (EVO) has a market capitalization of approximately $532.8 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does EVO pay a dividend?

No, Evotec SE (EVO) is not currently paying a dividend. Its last ex-dividend date was January 11, 2019 ($0.07 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### Is EVO profitable?

Evotec SE (EVO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often did EVO pay dividends?

Evotec SE paid dividends monthly until 2019; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is EVO's payout ratio?

Evotec SE's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/evo
- Dividend history & safety: https://www.dividenddata.com/stocks/evo/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/evo/earnings
- Financial statements: https://www.dividenddata.com/stocks/evo/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/evo/valuation
- Peer comparison: https://www.dividenddata.com/stocks/evo/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.